Botanical species · safety record

Descurainia sophia

The EFSA Compendium of Botanicals holds 11 constituent measurements and 1 adverse-effect record for Descurainia sophia. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Descurainia sophia (L.) Webb ex Prantl

11Constituent measurements
1Safety records
4Cited sources
29Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 29 licensed products naming Descurainia sophia as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Seed
  • Seed(s)

What the records describe

Constituents measured

  • 1,8-cineole1
  • Alpha-cedrol1
  • Bergapten1
  • Isoscopoletin1
  • Isothiocyanates1
  • Methoxsalen1
  • Psoralen1
  • Scopoletin1
  • Scopolin1
  • Tagetone1

Plant parts

  • Aerial part of plants7
  • Flowering top3
  • Seed1
  • Unspecified1

Preparations

  • Solvent extraction7
  • Essential oil4

Effect types

  • Digestive1

Target tissues

  • Digestive1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
1,8-cineoleFlowering topEssential oil2.58 PercentGC-MSResolve DOI
Alpha-cedrolFlowering topEssential oil1.43 PercentGC-MSResolve DOI
TagetoneFlowering topEssential oil1.04 PercentGC-MSResolve DOI
BergaptenAerial part of plantsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
IsoscopoletinAerial part of plantsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
IsothiocyanatesSeedEssential oilGC-MSNo resolvable identifier
MethoxsalenAerial part of plantsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
PsoralenAerial part of plantsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
ScopoletinAerial part of plantsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
ScopolinAerial part of plantsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
XanthotoxolAerial part of plantsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
DigestiveDigestiveUnspecifiedIn vitroNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Mohamed, Nawal H., Mahrous, Atta E. Chemical Constituents of Descurainia sophia L. and its Biological Activity . Records of natural products, 2009, vol. 3, no. 1, p. 58-67.
  2. Li, Jing., Liu, Xingang., Dong, Fengshou., Xu, Jun., Zheng, Yongquan., Shan, Weili. Determination of the Volatile Composition in Essential Oil of Descurainia sophia (L.) Webb ex Prantl (Flixweed) by Gas Chromatography/Mass Spectrometry (GC/MS) . Molecules, 2010, vol. 15, no. 1, p. 233-240. DOI
  3. Khodarahmi, E., Asghari, G. H., Hassanzadeh, F., Mirian, M., Khodarahmi, G. A. Cytotoxic evaluation of volatile oil from Descurainia sophia seeds on MCF-7 and HeLa cell lines . Research in pharmaceutical sciences, 2015, vol. 10, no. 2, p. 169-176.
  4. Zarei, Mohammad., Poursharifi, Mina. Searching for alpha-glucosidase inhibitory activity in hexane extracts by some plants from Kurdistan province. International journal of advanced biological and biomedical research, 2015, vol. 3, no. 3, p. 291-296.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue